- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Norland buys ultrasound densitometer
Competition may heat up soon in the developing ultrasound bone densitometry market. Bone densitometry vendor Norland has acquired rights to distribute worldwide all existing and future ultrasound bone measurement systems developed by Canadian vendor
Competition may heat up soon in the developing ultrasound bone densitometry market. Bone densitometry vendor Norland has acquired rights to distribute worldwide all existing and future ultrasound bone measurement systems developed by Canadian vendor IMRO.
The device developed by IMRO provides ultrasound bone measurement at the heel and will be sold by Norland as Paris. The bone department of McGill University in Toronto has selected the IMRO device to be used exclusively in an ongoing clinical study, according to White Plains, NY-based Norland.
Norland expects to begin marketing Paris shortly in Europe, Latin America, and the Pacific Rim, and an application for Food and Drug Administration 510(k) clearance should be filed by the end of the year, according to the company.
In other Norland news, shareholders have approved its acquisition of Norland Corp., the Ft. Atkinson, WI-based company that manufactures the DEXA (dual-energy x-ray absorptiometry) scanners that Norland distributes (SCAN 3/19/97).
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
